These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30014533)

  • 1. The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.
    Johnson NE; Heatwole C; Creigh P; McDermott MP; Dilek N; Hung M; Bounsanga J; Tang W; Shy ME; Herrmann DN
    Ann Neurol; 2018 Aug; 84(2):225-233. PubMed ID: 30014533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease.
    Ramchandren S; Shy M; Feldman E; Carlos R; Siskind C
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):635-9. PubMed ID: 25157034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
    Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
    Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.
    Mandarakas MR; Menezes MP; Rose KJ; Shy R; Eichinger K; Foscan M; Estilow T; Kennedy R; Herbert K; Bray P; Refshauge K; Ryan MM; Yiu EM; Farrar M; Sampaio H; Moroni I; Pagliano E; Pareyson D; Yum SW; Herrmann DN; Acsadi G; Shy ME; Burns J; Sanmaneechai O
    Brain; 2018 Dec; 141(12):3319-3330. PubMed ID: 30476010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the Charcot-Marie-Tooth functional outcome measure.
    Bray P; Cornett KMD; Estilow T; Pareyson D; Zuccarino R; Skorupinska M; Pipis M; Sowden JE; Scherer S; Reilly MM; Shy ME; Herrmann DN; Burns J; Eichinger KJ
    J Peripher Nerv Syst; 2020 Sep; 25(3):288-291. PubMed ID: 32844461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure.
    Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Muntoni F; Estilow T; Shy ME; Ramchandren S;
    J Peripher Nerv Syst; 2023 Jun; 28(2):237-251. PubMed ID: 36748295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale.
    Zuccarino R; Prada V; Moroni I; Pagliano E; Foscan M; Robbiano G; Pisciotta C; Cornett K; Shy R; Schenone A; Pareyson D; Shy M; Burns J
    J Peripher Nerv Syst; 2020 Jun; 25(2):138-142. PubMed ID: 32394473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease.
    Prada V; Robbiano G; Mennella G; Hamedani M; Bellone E; Grandis M; Schenone A; Zuccarino R
    J Peripher Nerv Syst; 2020 Dec; 25(4):413-422. PubMed ID: 33140522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).
    Eichinger K; Burns J; Cornett K; Bacon C; Shepherd ML; Mountain J; Sowden J; Shy R; Shy ME; Herrmann DN
    Neurology; 2018 Oct; 91(15):e1381-e1384. PubMed ID: 30232254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of illness in Charcot-Marie-Tooth neuropathy: Results from Germany.
    Schorling E; Thiele S; Gumbert L; Krause S; Klug C; Schreiber-Katz O; Reilich P; Nagels K; Walter MC
    Neurology; 2019 Apr; 92(17):e2027-e2037. PubMed ID: 30918088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor unit number index correlates with disability in Charcot-Marie-Tooth disease.
    Bas J; Delmont E; Fatehi F; Salort-Campana E; Verschueren A; Pouget J; Lefebvre MN; Grapperon AM; Attarian S
    Clin Neurophysiol; 2018 Jul; 129(7):1390-1396. PubMed ID: 29729594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis.
    Sadjadi R; Reilly MM; Shy ME; Pareyson D; Laura M; Murphy S; Feely SM; Grider T; Bacon C; Piscosquito G; Calabrese D; Burns TM
    J Peripher Nerv Syst; 2014 Sep; 19(3):192-6. PubMed ID: 25400013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the Manual Ability Measure-36 in persons with Charcot-Marie-Tooth disease.
    Poole JL; Huffman M; Hunter A; Mares C; Siegel P
    J Hand Ther; 2015; 28(4):364-7; quiz 368. PubMed ID: 26318522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of muscle cramps in Charcot-Marie-tooth disease.
    Johnson NE; Sowden J; Dilek N; Eichinger K; Burns J; Mcdermott MP; Shy ME; Herrmann DN
    Muscle Nerve; 2015 Apr; 51(4):485-8. PubMed ID: 25042364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.
    Murphy SM; Herrmann DN; McDermott MP; Scherer SS; Shy ME; Reilly MM; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):191-8. PubMed ID: 22003934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are novel outcome measures for Charcot-Marie-Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study.
    Pazzaglia C; Padua L; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Coraci D; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Neuromuscul Disord; 2019 Apr; 29(4):310-316. PubMed ID: 30926199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.